[144] Quest Diagnostics Inc. SEC Filing

Rhea-AI Filing Summary

On 28–29 Jul 2025, AmeriServ Financial (ASRV) EVP & CFO Michael D. Lynch bought a total of 3,500 common shares in two open-market purchases: 1,500 shares at $2.825 and 2,000 shares at $2.874. No shares were sold, and no derivative activity was reported. Lynch’s direct holding now stands at 17,832 shares, up from 14,332. The purchases represent an aggregate investment of roughly $9.9 thousand. While insider buying by a senior officer can be viewed as a confidence signal, the dollar amount is small relative to the bank’s market value, limiting the transaction’s market impact.

Positive

• CFO insider purchase: 3,500 shares added with no sales, indicating personal confidence in ASRV’s prospects.

Negative

• Limited scale: The ~$10k transaction is too small to materially affect ownership structure or valuation.

Insights

Financial Analyst

TL;DR: Modest insider buy by ASRV CFO; slight positive sentiment, immaterial financial impact.

The EVP/CFO’s acquisition of 3,500 shares (~$10k) without accompanying sales suggests personal conviction that the stock is undervalued. Such executive purchases often boost investor confidence, especially at community banks where management insight is valuable. However, the stake increase is minor—well below 1% of shares outstanding—so fundamental valuation and liquidity are unchanged. I see the filing as a marginally bullish sentiment indicator rather than a catalyst for re-rating.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2210	375700.00	111823441	07/31/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/24/2025	Restricted Stock Vesting	Issuer			1978	02/24/2025	Compensation
Common	02/23/2025	Restricted Stock Vesting	Issuer			232	02/23/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Karthikeyan Kuppusamy 500 Plaza Drive Secaucus, NJ 07094	Common	07/30/2025	8269	1384230.60

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many ASRV shares did the CFO purchase?

3,500 common shares were bought on 28–29 Jul 2025.

At what prices were the ASRV shares bought?

Purchases occurred at $2.825 and $2.874 per share.

What is Michael D. Lynch’s total ASRV ownership after the trades?

He now directly holds 17,832 common shares.

Were any ASRV shares sold or any derivatives exercised?

No; the filing reports only open-market purchases and shows no derivative activity.

Does this Form 4 filing materially impact ASRV stock?

The buy may signal confidence but is not large enough to alter fundamentals or near-term valuation.